Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
Definitive Healthcare Corp (NASDAQ: DH) closed the day trading at $3.28 down -1.20% from the previous closing price of $3.32. In other words, the price has decreased by -$1.20 from its previous closing price. On the day, 0.56 million shares were traded.
Ratios:
For a better understanding of DH, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.39 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 10.02. For the most recent quarter (mrq), Quick Ratio is recorded 1.66 and its Current Ratio is at 1.66. In the meantime, Its Debt-to-Equity ratio is 0.56 whereas as Long-Term Debt/Eq ratio is at 0.52.
On January 13, 2025, Barclays Downgraded its rating to Underweight which previously was Equal Weight but kept the price unchanged to $4.
On December 20, 2024, Stephens started tracking the stock assigning a Equal-Weight rating and target price of $5.Stephens initiated its Equal-Weight rating on December 20, 2024, with a $5 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 03 ’24 when Moschella William sold 45,000 shares for $4.70 per share. The transaction valued at 211,500 led to the insider holds 433,830 shares of the business.
Moschella William bought 45,000 shares of DH for $209,250 on Dec 03 ’24.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.94 while its Price-to-Book (P/B) ratio in mrq is 1.11.
Stock Price History:
Over the past 52 weeks, DH has reached a high of $6.26, while it has fallen to a 52-week low of $2.15. The 50-Day Moving Average of the stock is 17.42%, while the 200-Day Moving Average is calculated to be -17.75%.
Shares Statistics:
A total of 109.65M shares are outstanding, with a floating share count of 38.65M. Insiders hold about 63.99% of the company’s shares, while institutions hold 37.07% stake in the company.
Earnings Estimates
The stock of Definitive Healthcare Corp (DH) is currently drawing attention from 13.0 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is $0.06, with high estimates of $0.07 and low estimates of $0.05.
Analysts are recommending an EPS of between $0.23 and $0.2 for the fiscal current year, implying an average EPS of $0.21. EPS for the following year is $0.26, with 13.0 analysts recommending between $0.38 and $0.19.
Revenue Estimates
12 analysts predict $59.22M in revenue for the current quarter. It ranges from a high estimate of $59.55M to a low estimate of $58.64M. As of the current estimate, Definitive Healthcare Corp’s year-ago sales were $63.74MFor the next quarter, 12 analysts are estimating revenue of $59.22M. There is a high estimate of $59.62M for the next quarter, whereas the lowest estimate is $58.31M.
A total of 13 analysts have provided revenue estimates for DH’s current fiscal year. The highest revenue estimate was $238.3M, while the lowest revenue estimate was $234.69M, resulting in an average revenue estimate of $237.03M. In the same quarter a year ago, actual revenue was $252.2MBased on 13 analysts’ estimates, the company’s revenue will be $241.2M in the next fiscal year. The high estimate is $254.26M and the low estimate is $226.9M.
